Cyberonics Nabs Approval For Depression Device, Plans For Reimbursement

Cyberonics predicts reimbursement for VNS Therapy for treatment-resistant depression (TRD) will be fully secured by 2007, despite encountering protracted difficulties in gaining FDA approval